Stay updated on Combination Immuno-therapies in Advanced Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Combination Immuno-therapies in Advanced Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combination Immuno-therapies in Advanced Lung Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the full record for the FRACTION-Lung study, including its terminated status, treatment arms, eligibility criteria, locations, and outcome measures.
    Difference
    84%
    Check dated 2026-11-09T23:26:59.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-02T23:39:25.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-26T23:15:18.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T23:28:49.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T05:26:44.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, blocking access to the study record and preventing viewing of the trial details.
    Difference
    20%
    Check dated 2026-09-21T23:53:59.000Z thumbnail image

Stay in the know with updates to Combination Immuno-therapies in Advanced Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combination Immuno-therapies in Advanced Lung Cancer Clinical Trial page.